14.5K(top 0.1%)
papers
328.0K(top 0.1%)
citations
170(top 0.1%)
h-index
288(top 0.1%)
g-index
15.7K
all documents
352.7K
doc citations
14.7K
citing journals

Top Articles

#TitleJournalYearCitations
1Global Prevalence and Major Risk Factors of Diabetic RetinopathyDiabetes Care20123,439
2Sarcopenia in Asia: Consensus Report of the Asian Working Group for SarcopeniaJournal of the American Medical Directors Association20143,035
3Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trialLancet, The20172,771
4Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trialLancet, The20171,749
5A classification of chronic pain for ICD-11Pain20151,701
6Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11)Pain20191,547
7Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS)Age and Ageing20141,462
8Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trialsLancet Oncology, The20151,369
9Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III TrialJournal of Clinical Oncology20201,255
10Direct regulation of TWIST by HIF-1α promotes metastasisNature Cell Biology20081,187
112012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial designJournal of Interventional Cardiac Electrophysiology20121,167
12Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trialLancet, The20121,165
13The outbreak of COVID-19: An overviewJournal of the Chinese Medical Association20201,030
14First-line ceritinib versus platinum-based chemotherapy in advanced ALK -rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 studyLancet, The2017919
15Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trialLancet Oncology, The2015809
16HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation Developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the SociEuropace2007741
17Inflammation and the pathogenesis of atrial fibrillationNature Reviews Cardiology2015688
18The IASP classification of chronic pain for ICD-11: chronic primary painPain2019645
19Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysisBMJ: British Medical Journal2009634
20Positive Correlations of Oct-4 and Nanog in Oral Cancer Stem-Like Cells and High-Grade Oral Squamous Cell CarcinomaClinical Cancer Research2008592
21PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 ProjectJournal of Thoracic Oncology2018589
22Bmi1 is essential in Twist1-induced epithelial–mesenchymal transitionNature Cell Biology2010583
23Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trialLancet Oncology, The2015574
24The IASP classification of chronic pain for ICD-11: chronic neuropathic painPain2019571
25Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trialJournal of Hepatology2016567
26Prevalence and Causes of Fatal Outcome in Catheter Ablation of Atrial FibrillationJournal of the American College of Cardiology2009537
27MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinomaHepatology2009531
28A Review of SARS-CoV-2 and the Ongoing Clinical TrialsInternational Journal of Molecular Sciences2020530
29Influence of Methylenetetrahydrofolate Reductase ( MTHFR ) C677T Polymorphism, B Vitamins and Other Factors on Plasma Homocysteine and Risk of Thromboembolic Disease in ChineseJournal of the Chinese Medical Association2005517
30Noninvasive single-beat determination of left ventricular end-systolic elastance in humansJournal of the American College of Cardiology2001502
31Initiation of Atrial Fibrillation by Ectopic Beats Originating From the Superior Vena CavaCirculation2000494
322021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial FibrillationEuropace2021494
33EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implicationEuropace2016471
34EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implicationHeart Rhythm2017442
35Increase of mitochondria and mitochondrial DNA in response to oxidative stress in human cellsBiochemical Journal2000435
36Stem Cell Therapy for Liver Disease: Parameters Governing the Success of Using Bone Marrow Mesenchymal Stem CellsGastroenterology2008428
37Peginterferon alpha-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis BJournal of Viral Hepatitis2003427
38Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trialLancet Oncology, The2017427
39Mst1 inhibits autophagy by promoting the interaction between Beclin1 and Bcl-2Nature Medicine2013426
40Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancerBiochemical and Biophysical Research Communications2009422
41Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatmentFASEB Journal2002420
42Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trialLancet Oncology, The2019418
43Texture features for classification of ultrasonic liver imagesIEEE Transactions on Medical Imaging1992404
44Prevalence of psychiatric morbidity and psychological adaptation of the nurses in a structured SARS caring unit during outbreak: A prospective and periodic assessment study in TaiwanJournal of Psychiatric Research2007394
45Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinomaJournal of Hepatology2009369
46The Prevalence of Age-Related Macular Degeneration in AsiansOphthalmology2010369
47Clinical and microbiological characteristics of tigecycline non-susceptible Klebsiella pneumoniaebacteremia in TaiwanBMC Infectious Diseases2014369
48The Significance of Keratinized Mucosa on Implant Health: A Systematic ReviewJournal of Periodontology2013366
49Central or peripheral systolic or pulse pressure: which best relates to target organs and future mortality?Journal of Hypertension2009365
50Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic studyLancet Oncology, The2020364